AnalystsRoy Buchanan
Roy Buchanan's Stock Forecasts

Analyst Ranking
Top 1%
#47 out of 5163 analysts
Average Return
+99.4%
Win Rate
53%39 out of 74
Risk vs Reward
Poor
Good

Roy Buchanan's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Abivax SaABVX
+2,068.34%$6.38$138.34
2025-01-10 -
2025-12-30
Buy
Cidara Therapeutics IncCDTX
+1,085.19%$18.63$220.80
2025-05-09 -
2025-12-30
Buy
Cidara Therapeutics IncCDTX
+945.45%$21.12$220.80
2025-04-29 -
2025-12-30
Buy
Cidara Therapeutics IncCDTX
+874.19%$22.67$220.80
2025-06-02 -
2025-12-30
Buy
Cidara Therapeutics IncCDTX
+860.00%$23.00$220.80
2025-03-12 -
2025-12-30
Buy

Roy Buchanan Analyst Color

Get additional color on Roy Buchanan's coverage of popular stocks

Roy Buchanan's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Cidara Therapeutics IncCDTX
8Buy$173.00-21.65%Maintains
3 months ago
Assembly Biosciences IncASMB
1Buy$38.00+18.27%Initiates Coverage On
3 months ago
Dynavax Technologies CorpDVAX
8Buy$32.00+108.20%Reiterates
4 months ago
Enanta Pharmaceuticals IncENTA
14Buy$25.00+57.23%Maintains
5 months ago
Polypid LtdPYPD
2Buy$14.00+219.63%Maintains
6 months ago
Curevac NvCVAC
9Buy$10.00+123.21%Reiterates
7 months ago
An2 Therapeutics IncANTX
8Buy$2.00+85.19%Maintains
8 months ago
Inovio Pharmaceuticals IncINO
3Buy$18.00+922.73%Reiterates
10 months ago
Esperion Therapeutics IncESPR
3Buy$4.00+8.40%Reiterates
a year ago
Ironwood Pharmaceuticals IncIRWD
1Buy$14.00+320.42%Maintains
a year ago
Abivax SaABVX
1Buy$33.00-76.15%Reiterates
a year ago
Hookipa Pharma IncHOOK
2Buy$7.00N/AMaintains
a year ago
Gritstone Bio IncGRTSQ
4Buy$5.00N/AReiterates
a year ago
Arbutus Biopharma CorpABUS
5Buy$5.00N/AMaintains
a year ago
Pardes Biosciences IncPRDS
2Buy$5.00N/AMaintains
3 years ago
Argenx SeARGX
2Buy$448.00N/AMaintains
3 years ago
Cormedix IncCRMD
1Hold$16.00N/AMaintains
3 years ago
Ibio IncIBIO
1Buy$750.00N/AInitiates Coverage On
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.